Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schillinger, F.
Right arrow Articles by Montagnac, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schillinger, F.
Right arrow Articles by Montagnac, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1996) 11: 481-485
© 1996 European Renal Association-European Dialysis and Transplant Association


research-article

Chronic renal failure and its treatment in tuberous sclerosis

F. Schillinger and R. Montagnac

Department of Nephrology and Hemodialysis, General Hospital Troyes, France

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr F. Schillinger, Service de Néphrologie et d'Hémodialyse Hôpital de Troyes 10003 Troyes, France

BACKGROUND.: Chronic renal failure is rare in tuberous sclerosis, but its precise frequency is not known and treatment modalities have not been evaluated.

METHODS.: A questionnaire was addressed to the 260 French dialysis centres and the characteristics of 65 patients with tuberous sclerosis and chronic renal failure were analysed.

RESULTS.: In France the approximate prevalence of tuberous sclerosis with end-stage renal failure is 0.7 cases per million and that of end-stage renal failure in tuberous sclerosis 1 per 100. Tuberous sclerosis with chronic renal failure was more frequent in females (63.1%) and was diagnosed at a mean age of 29 years. Renal impairment was the first manifestation of tuberous sclerosis in about half the cases. Renal tumours were frequent, with angiomyolipomas in 15 cases (23.1%), cysts in 12 cases (18.5%), and both in 35 cases (53.8%). Malignancies were associated in nine cases (13.8%). Nephrectomy was done before dialysis in 21 cases (32.3%), and after the start of dialysis in six cases (9.2%). All but one of the 48 patients with end-stage renal failure were treated by dialysis; 20 were transplanted, with good results.

CONCLUSIONS.: Tuberous sclerosis with end-stage renal failure is rare. These patients require dialysis and renal transplantation, but we recommend binephrectomy after starting dialysis and before transplantation, given the risk of cancer and bleeding related to angiomyolipomas.

Keywords: angiomyolipomas; renal cell carcinomas; renal cysts; chronic renal failure; tuberous sclerosis; adenoma sebaceum


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Corsenca, F. Aebersold, H. Moch, P. Bird, M. Weber, G. Hofbauer, R. P. Wuthrich, and A. L. Serra
Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3330 - 3333.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Baron and A. Barkovich
MR Imaging of Tuberous Sclerosis in Neonates and Young
AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 907 - 916.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.